Iaso Therapeutics

Iaso Therapeutics is a startup spun off from Michigan State University. The company was founded in 2018 by Dr. Xuefei Huang. Dr. Huang is a Michigan State University Foundation Professor with a joint appointment in the Department of Chemistry and the Department of Biomedical Engineering at Michigan State University. Additionally, he is a member of the newly established Institute for Quantitative Health Science and Engineering. With over 25 years of experience, his research focuses on developing new technologies for next-generation vaccines, including those targeting cancer and infectious diseases. Iaso Therapeutics aims to translate cutting-edge technologies developed in the lab to promote human health and treat diseases.